In non-RT cancer cells, such as cervical cancer and glioma cells, loss of SNF5 failed to increase the expression of AURKA, and inhibition of AURKA expression did not sensitize these cells, suggesting that synthetic lethality between SNF5 and AURKA is cancer type-specific. The gene discussed is SMARCB1; the disease is glioma.